Overview
No overview information available.
Background
No background information available.
Indication
用于治疗复发型多发性硬化症（MS/罕见病），包括成人临床孤立综合征、复发-缓解性疾病和活动性继发进行性疾病。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/08/22 | Phase 2 | Completed | |||
2019/06/11 | Phase 1 | Active, not recruiting | |||
2015/07/16 | Phase 4 | Completed | |||
2013/10/16 | Phase 2 | Terminated | |||
2013/09/05 | Phase 3 | UNKNOWN | |||
2009/07/10 | Not Applicable | Completed | |||
2007/10/10 | Phase 1 | Suspended | |||
2007/06/25 | N/A | Completed | Nancy Hammond, MD | ||
2007/04/27 | Phase 2 | UNKNOWN | Kaplan Medical Center | ||
2007/03/23 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Glatiramer Acetate Injection | teva pharmaceuticals ltd | 国药准字HJ20230082 | 化学药品 | 注射剂 | 6/21/2023 |
| Glatiramer Acetate Injection | teva pharmaceuticals ltd | 国药准字HJ20230081 | 化学药品 | 注射剂 | 6/21/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||